Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.
Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.
复制标题
支链氨基酸的分解代谢缺陷促进心力衰竭
DOI:
10.1161/circulationaha.115.020226
复制
发表时间:
2016-05-24
期刊:
影响因子:
37.8
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Sun H;Olson KC;Gao C;Prosdocimo DA;Zhou M;Wang Z;Jeyaraj D;Youn JY;Ren S;Liu Y;Rau CD;Shah S;Ilkayeva O;Gui WJ;William NS;Wynn RM;Newgard CB;Cai H;Xiao X;Chuang DT;Schulze PC;Lynch C;Jain MK;Wang Y
Although metabolic reprogramming is critical in the pathogenesis of heart failure, studies to date have focused principally on fatty acid and glucose metabolism. Contribution of amino acid metabolic regulation in the disease remains understudied. Transcriptomic and metabolomic analyses were performed in mouse failing heart induced by pressure-overload. Suppression of branched-chain amino acids (BCAAs) catabolic gene expression along with concomitant tissue accumulation of branched-chain α-keto acids (BCKAs) was identified as a significant signature of metabolic reprogramming in mouse failing hearts, and validated to be shared in human cardiomyopathy hearts. Molecular and genetic evidence identified the transcription factor KLF15 as a key upstream regulator of the BCAA catabolic regulation in the heart. Studies using a genetic mouse model revealed that BCAA catabolic defect promoted heart failure associated with induced oxidative stress and metabolic disturbance in response to mechanical overload. Mechanistically, elevated BCKA directly suppressed respiration and induced superoxide production in isolated mitochondria. Finally, pharmacological enhancement of branched-chain α-keto acid dehydrogenase activity significantly blunted cardiac dysfunction following pressure-overload. BCAA catabolic defect is a metabolic hallmark of failing heart resulted from KLF15 mediated transcriptional reprogramming. BCAA catabolic defect imposes a previously unappreciated significant contribution to heart failure.